Medicines shortages are a problem for many European countries. Now is the time to act, to save the availability of critical generic medicines for patients across the region.
In this report, we explore how a policy framework can help sustain the pharmaceutical ecosystem in Europe and ensure the critical and affordable supply of essential high-quality medicines to European patients for years to come.
An analysis of generic medicine supply challenges, and the need to protect patient access